Enzyme Finance or Index Coop: Which Fits Your Needs in 2026?

Choose based on what you want to do. Enzyme is infrastructure for businesses and finance professionals: Onyx supports issuing and administering tokenized funds and financial instruments, Blue is for curating decentralized strategies, and Myso supports onchain covered calls and cash-secured puts. It also offers APIs, SDKs and white-label options for businesses building their own interfaces.

Index Coop is more directly aimed at DeFi users. It offers onchain index products alongside leverage tokens and Smart Loops, which automate parts of yield and leveraged strategies. That can simplify some strategy management, but it does not make the products equivalent to a simple, low-risk index fund. If you want fund administration or business integrations, start with Enzyme. If you want a wallet-based route to onchain index or automated strategy products, assess Index Coop.

Neither platform publishes one complete fee schedule for all products. Enzyme directs prospective Onyx customers to request pricing, and you should not assume the same charges apply to Onyx, Blue and Myso. Ask for a written breakdown of setup, administration, integration and any usage-based charges. Network transaction costs may be additional.

Index Coop also requires product-by-product cost checks. Your total expense may include the product’s stated costs, blockchain gas and costs from lending markets or other protocols used by a strategy. These can vary with network activity and market conditions. Before you commit, compare the full expected cost with the product’s purpose and risks—not just a headline fee. If a clear, fixed price is essential before you evaluate a service, neither currently offers one consolidated schedule to rely on.

Both involve smart-contract and onchain risks, and neither audit counts as a guarantee against loss. Enzyme lists two audits, but their scope and coverage of current products need confirmation. Ask for the reports and check which deployed contracts they cover. Enzyme describes its products as compliance-ready, but that does not establish a licence for Enzyme or confirm that your particular product meets legal requirements. Its custody arrangements also need to be confirmed for your intended use.

Index Coop advertises more than eight audits and an ongoing bug bounty. Check the reports for the specific contracts you plan to use. Its strategies can depend on lending markets and other DeFi protocols, so contract bugs, market failures and liquidation can cause losses. Index Coop’s licence status is not established; do not assume deposit insurance or a recovery process. For either option, verify permissions, asset controls and exit arrangements before committing funds.

Index Coop has the more direct starting point for an individual DeFi user: it directs users to a trading app, and you need a compatible wallet and the network’s native asset for gas. Check that your chosen product is available on your selected chain, then verify the token address, approvals and current liquidity before confirming a transaction. Automated management does not remove the need to understand the strategy.

Enzyme’s products serve different business and financial use cases, so there is no single retail sign-up path to assume. Its listed networks are Ethereum, Polygon and Arbitrum, but product availability may differ. Confirm the exact deployment, supported assets and any bridge or settlement dependencies. If you are evaluating Enzyme for a fund or business, expect to clarify product access and commercial terms with the company rather than treating it as a straightforward buy-and-hold app.

Enzyme stands out for its range of infrastructure: tokenized fund issuance and administration, decentralized strategy management, options products, APIs and white-label possibilities. That range may suit an issuer or manager building a financial product, but you need to assess the specific Enzyme product, custody model, legal terms and pricing—not the brand in the abstract. It is a poor fit if you want a simple retail investing app.

Index Coop’s distinguishing feature is automating parts of complex DeFi strategies through products such as Smart Loops. Some strategies promote high leverage, which can magnify losses and lead to liquidation; no return is guaranteed. Index Coop also restricts token acquisition for U.S. persons and people in jurisdictions where purchase is unlawful, prohibited or unauthorized. Check current eligibility terms before proceeding. Pick it only if you understand the product mechanics and can accept the risks.